EP0973741 - S-2'-(2-(1-METHYL-2-PIPERIDYL) ETHYL) CINNAMANILIDE AS A 5-HT2 RECEPTOR ANTAGONIST [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.04.2004 Database last updated on 19.07.2024 | Most recent event Tooltip | 22.04.2005 | Lapse of the patent in a contracting state New state(s): LU | published on 08.06.2005 [2005/23] | Applicant(s) | For all designated states Amer, M. Samir 877 sandpoint Road Carpenteria, CA 93013 / US | [N/P] |
Former [2000/04] | For all designated states AMER, M. Samir 877 sandpoint Road Carpenteria, CA 93013 / US | Inventor(s) | 01 /
see applicant ... | [2000/04] | Representative(s) | Ebner von Eschenbach, Jennifer, et al Ladas & Parry LLP Dachauerstrasse 37 80335 München / DE | [N/P] |
Former [2002/09] | Ebner von Eschenbach, Jennifer, et al Ladas & Parry, Dachauerstrasse 37 80335 München / DE | ||
Former [2000/04] | Baillie, Iain Cameron, et al Ladas & Parry, Dachauerstrasse 37 80335 München / DE | Application number, filing date | 98903668.6 | 23.01.1998 | [2000/04] | WO1998US01304 | Priority number, date | US19970810503 | 28.02.1997 Original published format: US 810503 | [2000/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9838165 | Date: | 03.09.1998 | Language: | EN | [1998/35] | Type: | A1 Application with search report | No.: | EP0973741 | Date: | 26.01.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.09.1998 takes the place of the publication of the European patent application. | [2000/04] | Type: | B1 Patent specification | No.: | EP0973741 | Date: | 11.06.2003 | Language: | EN | [2003/24] | Search report(s) | International search report - published on: | EP | 03.09.1998 | Classification | IPC: | C07D211/26, A61K31/445 | [2000/04] | CPC: |
C07D211/26 (EP,KR,US);
A61P17/02 (EP);
A61P23/02 (EP);
A61P25/04 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/14 (EP)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/04] | Title | German: | S-2'-(2-(1-METHYL-2-PIPERIDYL) ETHYL) CINNAMANILIDE ALS 5-HT2 REZEPTOR ANTAGONIST | [2000/04] | English: | S-2'-(2-(1-METHYL-2-PIPERIDYL) ETHYL) CINNAMANILIDE AS A 5-HT2 RECEPTOR ANTAGONIST | [2000/04] | French: | S-2'-(2-(1-METHYL-2-PIPERIDYL)ETHYL)CINNAMANILIDE EN TANT QU'ANTAGONISTE DU RECEPTEUR DE 5-HT2 | [2000/04] | Entry into regional phase | 23.06.1999 | National basic fee paid | 23.06.1999 | Designation fee(s) paid | 23.06.1999 | Examination fee paid | Examination procedure | 18.06.1998 | Request for preliminary examination filed International Preliminary Examining Authority: US | 23.06.1999 | Examination requested [2000/04] | 11.09.2000 | Despatch of a communication from the examining division (Time limit: M06) | 13.03.2001 | Reply to a communication from the examining division | 14.08.2001 | Despatch of a communication from the examining division (Time limit: M06) | 18.02.2002 | Reply to a communication from the examining division | 26.11.2002 | Date of oral proceedings | 05.12.2002 | Minutes of oral proceedings despatched | 13.12.2002 | Communication of intention to grant the patent | 10.04.2003 | Fee for grant paid | 10.04.2003 | Fee for publishing/printing paid | Opposition(s) | 12.03.2004 | No opposition filed within time limit [2004/23] | Fees paid | Renewal fee | 28.12.1999 | Renewal fee patent year 03 | 28.12.2000 | Renewal fee patent year 04 | 03.01.2002 | Renewal fee patent year 05 | 22.01.2003 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 11.06.2003 | BE | 11.06.2003 | FI | 11.06.2003 | NL | 11.06.2003 | DK | 11.09.2003 | GR | 11.09.2003 | PT | 11.09.2003 | SE | 11.09.2003 | IE | 23.01.2004 | LU | 23.01.2004 | MC | 31.01.2004 | [2005/23] |
Former [2005/03] | AT | 11.06.2003 | |
BE | 11.06.2003 | ||
FI | 11.06.2003 | ||
NL | 11.06.2003 | ||
DK | 11.09.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
SE | 11.09.2003 | ||
IE | 23.01.2004 | ||
MC | 31.01.2004 | ||
Former [2005/02] | AT | 11.06.2003 | |
BE | 11.06.2003 | ||
FI | 11.06.2003 | ||
NL | 11.06.2003 | ||
DK | 11.09.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
SE | 11.09.2003 | ||
MC | 31.01.2004 | ||
Former [2004/29] | AT | 11.06.2003 | |
BE | 11.06.2003 | ||
CH | 11.06.2003 | ||
FI | 11.06.2003 | ||
LI | 11.06.2003 | ||
NL | 11.06.2003 | ||
DK | 11.09.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
SE | 11.09.2003 | ||
Former [2004/28] | AT | 11.06.2003 | |
BE | 11.06.2003 | ||
CH | 11.06.2003 | ||
FI | 11.06.2003 | ||
LI | 11.06.2003 | ||
NL | 11.06.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
SE | 11.09.2003 | ||
Former [2004/10] | AT | 11.06.2003 | |
CH | 11.06.2003 | ||
FI | 11.06.2003 | ||
LI | 11.06.2003 | ||
NL | 11.06.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
SE | 11.09.2003 | ||
Former [2004/05] | AT | 11.06.2003 | |
CH | 11.06.2003 | ||
FI | 11.06.2003 | ||
LI | 11.06.2003 | ||
NL | 11.06.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
Former [2004/03] | AT | 11.06.2003 | |
CH | 11.06.2003 | ||
LI | 11.06.2003 | ||
NL | 11.06.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
Former [2004/02] | CH | 11.06.2003 | |
LI | 11.06.2003 | ||
NL | 11.06.2003 | ||
GR | 11.09.2003 | ||
PT | 11.09.2003 | ||
Former [2004/01] | CH | 11.06.2003 | |
LI | 11.06.2003 | Cited in | International search | [DXY]US4064254 (DYKSTRA STANLEY JOHN [US], et al) [DX] 1-4,8-25 * example 141 * * example 141A * [Y] 5-7; | [DX]WO9418958 (SAM AMER & CO INC [US], et al) [DX] 8-25 * see compound I; page 11 *; | [Y]WO9521819 (MERCK SHARP & DOHME [GB], et al) [Y] 5-7 * page 10, line 29 - line 30 * * page 28, line 23 - line 33 *; | [Y] - PORTOGHESE, PHILIP S. ET AL, "Stereochemical studies on medicinal agents. 13. Correlation of the solid-state conformations of 1,3,5-trimethyl- and 1,3-dimethyl-4-phenyl-4-propionoxypiperidine enantiomers with their absolute stereoselectivity at analgetic receptors", J. MED. CHEM. (1973), 16(3), 199-203 CODEN: JMCMAR, (1973), XP002061306 [Y] 5-7 * see optical resolution of compound 5 * DOI: http://dx.doi.org/10.1021/jm00261a006 |